Maximal glomerular diameter as a 10-year prognostic indicator for IgA nephropathy

Nephrology Dialysis Transplantation

Volumn 26, Issue 12, 2011, Pages 3937-3943

  Kataoka, Hiroshi ^a   Ohara, Mamiko ^b   Honda, Kazuho ^a   Mochizuki, Takahiro ^b   Nitta, Kosaku ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b KAMEDA MEDICAL CENTER   (Japan)

Author keywords

glomerular hypertrophy; glomerular size; IgA nephropathy; prognosis; renal biopsy

Indexed keywords

CREATININE; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGE; AGED; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEMATURIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; KIDNEY FUNCTION; KIDNEY HYPERTROPHY; MALE; MAXIMAL GLOMERULAR DIAMETER; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEINURIA; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SURVIVAL; TRIACYLGLYCEROL BLOOD LEVEL; UROGENITAL SYSTEM PARAMETERS;

ADOLESCENT; ADULT; AGED; FEMALE; GLOMERULONEPHRITIS, IGA; HUMANS; KIDNEY GLOMERULUS; MALE; MIDDLE AGED; ORGAN SIZE; PROGNOSIS; TIME FACTORS; YOUNG ADULT;

EID: 82255194338     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr139     Document Type: Article

References (39)

1. Maisonneuve P, Agodoa L, Gellert R et al. Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: results from an international comparative study. Am J Kidney Dis 2000; 35: 157-165 (Pubitemid 30027256)
2. Barratt J, Feehally J. IgA nephropathy. J Am Soc Nephrol 2005; 16: 2088-2097 (Pubitemid 41716440)
3. D'Amico G. Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol 2004; 24: 179-196 (Pubitemid 38685989)
4. Bartosik LP, Lajoie G, Sugar L et al. Predicting progression in IgA nephropathy. Am J Kidney Dis 2001; 38: 728-735
5. Feehally J. Predicting prognosis in IgA nephropathy. Am J Kidney Dis 2001; 38: 881-883 (Pubitemid 32927916)
6. Haas M. Histological subclassification of IgA nephropathy: a clinicopathologic study of 244 cases. Am J Kidney Dis 1997; 29: 829-842 (Pubitemid 27251835)
7. Tomino Y, Sakai H. Clinical guidelines for immunoglobulin A (IgA) nephropathy in Japan, second version. Clin Exp Nephrol 2003; 7: 93-97 (Pubitemid 36898685)
8. Lee HS, Lee MS, Lee SM et al. Histological grading of IgA nephropathy predicting renal outcome: revisiting HS Lee's glomerular grading system. Nephrol Dial Transplant 2005; 20: 342-348 (Pubitemid 40276890)
9. Shimizu A, Takei T, Uchida K et al. Predictors of poor outcomes in steroid therapy for immunoglobulin A nephropathy. Nephrology 2009; 14: 521-526
10. Roufosse CA, Cook HT. Pathological predictors of prognosis in immunoglobulin A nephropathy: a review. Curr Opin Nephrol Hypertens 2009; 18: 212-219
11. Alamartine E, Sabatier JC, Guerin C et al. Prognostic factors in mesangial IgA glomerulonephritis: an extensive study with univariate and multivariate analyses. Am J Kidney Dis 1991; 18: 12-19
12. Abdi R, Slakey D, Kittur D et al. Heterogeneity of glomerular size in normal donor kidneys. Impact of race.AmJ Kidney Dis 1998; 32: 43-46 (Pubitemid 28311869)
13. Schmidt K, Pesce C, Liu Q et al. Large glomerular size in Pima Indians: lack of change with diabetic nephropathy. J Am Soc Nephrol 1992; 3: 229-235
14. Young RJ, Hoy WE, Kincaid-Smith P et al. Glomerular size and glomerulosclerosis in Australian aborigines. Am J Kidney Dis 2000; 36: 481-489
15. Tsuboi N, Kawamura T, Ishii T et al. Changes in the glomerular density and size in serial renal biopsies during the progression of IgA nephropathy. Nephrol Dial Transplant 2009; 24: 892-899
16. Imai E, Horio M, Nitta K et al. Modification of the Modification of Diet in Renal Disease (MDRD) Study equation from Japan. Am J Kidney Dis 2007; 50: 927-937 (Pubitemid 350130278)
17. Taneda S, Honda K, Nitta K et al. Clinicopathological study of IgA nephropathy in adults: the influence on onset age on clinical and renal histological findings and on the effect of steroid therapy. Clin Exp Nephrol 1999; 3: 96-103 (Pubitemid 29317917)
18. Roberts ISD, Cook T et al. A Working Group of the International IgA Nephropathy Network and the Renal Pathology Society. The Oxford classification of IgA Nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int 2009; 76: 546-556
19. Cattran D, Coppo R et al. A Working Group of the International IgA Nephropathy Network and the Renal Pathology Society. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations and classification. Kidney Int 2009; 76: 534-545
20. Fries JW, Sandstrom DJ, Rennke HG et al. Glomerular hypertrophy and epithelial cell injury modulate progressive glomerulosclerosis in the rat. Lab Invest 1989; 60: 205-218 (Pubitemid 19072404)
21. Miller PL, Rennke HG, Meyer TW. Glomerular hypertrophy accelerates hypertensive glomerular injury in rats. Am J Physiol 1991; 261: 459-465
22. Toyota E, Ogasawara Y, Fujimoto K et al. Global heterogeneity of glomerular volume distribution in early diabetic nephropathy. Kidney Int 2004; 66: 855-861 (Pubitemid 38982031)
23. Cahill MM, Ryan GB, Bertram JF. Biphasic glomerular hypertrophy in rats administered puromycin aminonucleoside. Kidney Int 1996; 50: 768-775 (Pubitemid 26302664)
24. Fogo A, Hawkins EP, Berry PL et al. Glomerular hypertrophy in minimal change disease predicts subsequent progression to focal glomerular sclerosis. Kidney Int 1990; 38: 115-123 (Pubitemid 20209440)
25. Østerby R, Gundersen HJG. Glomerular size and structure in diabetes mellitus. I. Early abnormalities. Diabetologia 1975; 11: 225-229
26. Zerbini G, Bonfanti R, Meschi F et al. Persistent renal hypertrophy and faster decline of glomerular filtration rate precede the development of microalbuminuria in type 1 diabetes. Diabetes 2006; 55: 2620-2625 (Pubitemid 44871164)
27. Samuel T, Hoy WE, Douglas-Denton R et al. Applicability of the glomerular size distribution coefficient in assessing human glomerular volume: the Weibel and Gomez method revisited. J Anat 2007; 210: 578-582 (Pubitemid 46647825)
28. Yoshida Y, Kawamura T, Ichikawa I et al. Effects of antihypertensive drugs on glomerular morphology. Kidney Int 1989; 36: 626-635 (Pubitemid 19239554)
29. Olson JL, Heptinstall RH. Nonimmunologic mechanisms of glomerular injury. Lab Invest 1988; 59: 564-578
30. Schmitz A, Gundersen HJ, Osterby R. Glomerular morphology by light microscopy in non-insulin-dependent diabetes mellitus. Lack of glomerular hypertrophy. Diabetes 1988; 37: 38-43 (Pubitemid 18036455)
31. Lane PH, Steffes MW, Mauer SM. Estimation of glomerular volume: a comparison of four methods. Kidney Int 1992; 41: 1085-1089
32. Olivetti G, Anversa P, Rigamonti W et al. Morphometry of the renal corpuscle during normal postnatal growth and compensatory hypertrophy. A light microscope study. J Cell Biol 1977; 75: 573-585 (Pubitemid 8205007)
33. El-Khatib MT, Becker GJ, Kincaid-Smith PS. Morphometric aspects of reflux nephropathy. Kidney Int 1987; 32: 261-266 (Pubitemid 17130797)
34. Bhathena DB. Focal glomerulosclerosis and maximal glomerular hypertrophy in human nephronopenia. J Am Soc Nephrol 1996; 7: 2600-2603 (Pubitemid 27469566)
35. Cohen AH. Massive obesity and the kidney. A morphologic and statistical study. Am J Pathol 1975; 81: 117-130
36. Zandi-Nejad K, Luyckx VA, Brenner BM. Adult hypertension and kidney disease: the role of fetal programming. Hypertension 2006; 47: 502-508 (Pubitemid 43843866)
37. Osterby R, Asplund J, Walker JD et al. Glomerular volume and the glomerular vascular pole area in patients with insulin-dependent diabetes mellitus. Virchows Arch 1997; 431: 351-357 (Pubitemid 27487531)
38. Al-Awqati Q, Preisig PA. Size does matter: will knockout of p21(WAF1/CIP1) save the kidney by limiting compensatory renal growth? Proc Natl Acad Sci USA 1999; 96: 10551-10553 (Pubitemid 29442175)
39. Shea SM, Raskova J, Morrison AB. A stereologic study of glomerular hypertrophy in the subtotally nephrectomized rat. Am J Pathol 1978; 90: 201-210 (Pubitemid 8257486)